High importance
Oct 14, 2026
Recognizing HHT in patients with heavy menstrual bleeding can lead to improved clinical outcomes and tailored treatment strategies, ultimately enhancing care for this patient demographic.
To evaluate the impact of hereditary hemorrhagic telangiectasia (HHT) on heavy menstrual bleeding (HMB) in adolescents and young adults (AYAs).
HHT is frequently underrecognized in AYAs presenting with HMB, requiring consideration in differential diagnoses, particularly for those exhibiting characteristic symptoms or with a family background of HHT.
A review of clinical features, family history, and management strategies for heavy menstrual bleeding in the context of HHT, alongside a literature synthesis on related bleeding disorders.
Limited evidence and research regarding the management of HMB in individuals with HHT, influenced by underreporting due to stigma associated with menstrual bleeding.
For your doctor:
PMID: 42872963
DOI: 10.1002/1545-5017.70764
To understand the effect of hereditary hemorrhagic telangiectasis (HHT) on uterine bleeding is paramount to improving clinical care of menstruating individuals with HHT. Heavy menstrual bleeding (HMB) in adolescents and young adults (AYAs) with HHT is underrecognized and among individuals with HMB, HHT should be considered in the differential diagnosis, especially among those with suggestive clinical features or family history. Stigmatization associated with vaginal blood loss likely contributes to the paucity of evidence to guide HMB management in individuals with HHT, as previously reported in von Willebrand disease and other inherited bleeding disorders.